Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial

Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial

Abstract The GUSTO clinical trial (Gene expression subtypes of Urothelial carcinoma: Stratified Treatment and Oncological outcomes) uses molecular subtypes to guide neoadjuvant therapies in participants with muscle‐invasive bladder cancer (MIBC). Before commencing the GUSTO trial, we needed to deter...

Full description

Bibliographic Details
Main Authors: Jon Griffin, Jenny Down, Lewis A Quayle, Paul R Heath, Ewan A Gibb, Elai Davicioni, Yang Liu, Xin Zhao, Jayne Swain, Dennis Wang, Syed Hussain, Simon Crabb, James WF Catto, the GUSTO Trial Management Group
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:The Journal of Pathology: Clinical Research
Subjects:
urothelial carcinoma
molecular pathology
gene expression subtypes
Online Access:https://doi.org/10.1002/2056-4538.12363

Internet

https://doi.org/10.1002/2056-4538.12363

Similar Items